共 276 条
[1]
Kuang H(2021)Sacubitril/valsartan in chronic kidney disease: from pharmacological mechanism to clinical application Eur J Pharmacol 907 174288-1172
[2]
Huang X(2021)Effects of SGLT2 inhibitors on renal outcomes in patients with chronic kidney disease: a meta-analysis Front Med 8 728089-1245
[3]
Zhou Z(2021)Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options Circulation 143 1157-517
[4]
Cheng X(2020)Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: a meta-analysis Eur J Pharmacol 884 173444-498
[5]
Xu G(2021)Effect of angiotensin–neprilysin versus renin–angiotensin system inhibition on renal outcomes: a systematic review and meta-analysis Front Pharmacol 12 604017-652
[6]
Li N(2020)Angiotensin–neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction Circulation 142 1236-1514
[7]
Lv D(2015)Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction Eur J Heart Fail 17 510-565
[8]
Zhu X(2018)Renal effects and associated outcomes during angiotensin–neprilysin inhibition in heart failure JACC Heart Fail 6 489-1395
[9]
Wei P(2019)Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view Nefrologia 39 646-548
[10]
Gui Y(2018)Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease Circulation 138 1505-1620